Comparison of Partial and Radical Laparascopic Nephrectomy: Long-Term Outcomes for Clinical T1b Renal Cell Carcinoma

Yi Cai, Han-Zhong Li, Yu-Shi Zhang



Purpose: To compare the long-term clinical and oncologic outcomes in patients treated with laparoscopic partial nephrectomy (LPN) and laparoscopic radial nephrectomy (LRN) for clinical T1b renal cell carcinoma.
Materials and Methods: We retrospectively reviewed the records of all patients who underwent LPN or LRN for a single clinical T1b tumor between January 2005 and January 2012, an actual follow-up of 2-year or greater was available in 39 and 160 after LPN and LRN, respectively. Survival was calculated using the Kaplan-Meier method. Multivariable Cox regression analysis was done to assess predictors of survival.
Results: The two cohorts of patients were similar in age, sex, body-mass index and preoperative eGFR. There were no differences in tumors size (4.97 vs 5.29cm, P = .08), and pathological stage distribution between the two cohorts. The median follow-up after LPN and LRN were 67 (range: 18-118) and 70 (19-120) months, respectively. For LPN versus LRN, 5-years overall and cancer specific survival rates were 93.33% vs 85.69% and 96.00% vs 91.35%, respectively. For LPN versus LRN, 10-years overall and cancer specific survival rates were 85.56% vs
73.41% and 88.00% vs 82.85%, respectively. On multivariate analysis, patients’ age, ASA score and pathological stage were the major factors affecting overall survival, and patients’ age and pathological stage were associated with cancer specific survival. The percent decrease in glomerular filtration rate was significantly lower in the LRN group at early and last followup.
Conclusion: LPN is an effective treatment option in appropriately selected patients with cT1b RCC. It provides 5-year, 10-year overall survival and cancer specific survival comparable to those of LRN as well as better preservation of renal function than LRN. Overall survival and cancer specific survival are associated with nonmodifiable factors but not by the choice of operative technique.

Full Text:




Ljungberg B, Bensalah K, Canfield S, et al. EAU Guidelines on Renal Cell Carcinoma: 2014 Update. Eur Urol. 2015;67:913-24.

Liss MA, Wang S, Palazzi K, et al. Evaluation of national trends in the utilization of partial nephrectomy in relation to the publication of the American Urologic Association guidelines

for the management of clinical T1 renal masses. BMC Urol. 2014;14:101.

Karakiewicz PI, Lewinshtein DJ, Chun FK, et al. Tumor size improves the accuracy of TNM predictions in patients with renal cancer. Eur Urol. 2006;50:521-8; discussion 9.

Volpe A, Amparore D, Mottrie A. Treatment outcomes of partial nephrectomy for T1b tumours. Curr Opin Urol. 2013;23:403-10.

M Crépel CJ, P Perrotte , U Capitanio , H Isbarn , SF Shariat , D Liberman , M Sun , G Lughezzani , P Arjane , H Widmer , M Graefen, F Montorsi , J Patard , PI Karakiewicz Nephron-sparing Surgery Is Equally Effective to Radical Nephrectomy for T1BN0M0

Renal Cell Carcinoma: A Population-based Assessment. Urology. 2010;75:271-5.

Simmons MN, Chung BI, Gill IS. Perioperative efficacy of laparoscopic partial nephrectomy for tumors larger than 4 cm. Eur Urol. 2009;55:199-207.

Aron M, Gill IS. Minimally invasive nephronsparing surgery (MINSS) for renal tumours part I: laparoscopic partial nephrectomy. Eur Urol. 2007;51:337-46; discussion 46-7.

Deklaj T, Lifshitz DA, Shikanov SA, Katz MH, Zorn KC, Shalhav AL. Laparoscopic radical versus laparoscopic partial nephrectomy for clinical T1bN0M0 renal tumors: comparison of perioperative, pathological, and functional outcomes. J Endourol. 2010;24:1603-7.

Alyami FA, Rendon RA. Laparoscopic partial nephrectomy for > 4 cm renal masses. Can Urol Assoc J. 2013;7:E281-6.

Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from

serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-70.

Milonas D, Skulcius G, Baltrimavicius R, et al. Comparison of long-term results after nephron-sparing surgery and radical

nephrectomy in treating 4- to 7-cm renal cell carcinoma. Medicina (Kaunas). 2013;49:223-8.

Lee HJ, Liss MA, Derweesh IH. Outcomes of partial nephrectomy for clinical T1b and T2 renal tumors. Curr Opin Urol. 2014;24:448-52.

Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2011;59:543-52.

Ani I, Finelli A, Alibhai SM, Timilshina N, Fleshner N, Abouassaly R. Prevalence and impact on survival of positive surgical margins in partial nephrectomy for renal cell carcinoma: a population-based study. BJU Int. 2013;111:E300-5.

Favaretto RL, Sanchez-Salas R, Benoist N, et al. Oncologic outcomes after laparoscopic partial nephrectomy: mid-term results. J Endourol. 2013;27:52-7.

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and

hospitalization. N Engl J Med. 2004;351:1296-305.

Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a

retrospective cohort study. Lancet Oncol. 2006;7:735-40.

Mukkamala A, He C, Weizer AZ, et al. Longterm renal functional outcomes of minimally invasive partial nephrectomy for renal cell carcinoma. Urol Oncol. 2014;32:1247-51.

RH Thompson SB, CM Lohse , BC Leibovich, ED Kwon , JC Cheville , ML Blute Radical Nephrectomy for pT1a Renal Masses May be Associated With Decreased Overall Survival

Compared With Partial Nephrectomy. The J Urol. 2008;179:468-73.


Creative Commons License 
This work is licensed under a Creative Commons Attribution 3.0 License